Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 30 OTHER_GOV 2 NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 927 Neoplasms 609 Breast Neoplasms 605 Colorectal Neoplasms 458 Neoplasm Metastasis 394 Ovarian Neoplasms 328 Melanoma 313 Prostatic Neoplasms 311 Lung Neoplasms 294 Multiple Myeloma 292 Recurrence 278 Squamous Cell Carcinoma of Head and Neck 246 Stomach Neoplasms 229 Pancreatic Neoplasms 229 Leukemia, Myeloid, Acute 220 Triple Negative Breast Neoplasms 191 Endometrial Neoplasms 190 Carcinoma, Renal Cell 182 Lymphoma, Non-Hodgkin 179 Carcinoma, Hepatocellular 177 Small Cell Lung Carcinoma 165 Leukemia, Lymphocytic, Chronic, B-Cell 156 Advanced Solid Tumors 156 Lymphoma, Follicular 148 Urinary Bladder Neoplasms 139 Lymphoma, Large B-Cell, Diffuse 138 Lymphoma 137 Advanced Solid Tumor 137 Uterine Cervical Neoplasms 134 Head and Neck Neoplasms 134

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Behavior × 1 year × Clear all

NCT05864846 2026-04-27

EpiCom

Jazz Pharmaceuticals

Phase 4 Completed

Behavior, Seizures, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡